Sequoia Capital-backed BrightGene Raises $75m In Shanghai IPO

Business - Published date: Friday November 08, 2019.

Sequoia Capital-backed Chinese biopharma firm BrightGene has collected 521 million yuan ($75 million) in its initial pu... Read more